Showing 110 results
July 2023
-
Media ReleaseScreening, multistakeholder collaboration, innovation, patient-centricity keys to enhancing breast cancer careA nationwide breast cancer screening program, multistakeholder collaboration, innovation, and patient-centricity are key factors in enhancing breast cancer care in the country. These were the main…
-
Media Release Partnerships and CommitmentsBreast CancerInspiring Conversations on Breast Cancer: Roundtable Series to Improve Survivorship in the PhilippinesThe first of a series of roundtable discussions aiming to promote awareness on breast cancer and help address gaps in breast cancer care kicked off today with key stakeholders from the public and…
June 2023
-
Media Release Achievements and AnnouncementsNovartis contributes to rebuilding PH post-pandemic economy, strengthening country's health care systemIn 2022, Novartis contributed PHP 7.5 billion to the Gross Domestic Product (GDP). Nineteen percent (19%) of our total GDP contribution in the Philippines stems from innovation (R&D) The full…
-
Media Release Partnerships and CommitmentsBreast CancerNovartis, Philippine Press Institute, ICanServe Foundation partner on media workshop to enhance breast cancer knowledgeMedia plays an important role in promoting public awareness on good health practices and disease prevention. Recognizing the key role of media in health literacy promotion, Novartis Healthcare…
March 2023
-
Media Release Achievements and AnnouncementsBreast CancerNovartis' Ribociclib Phase III NATALEE trial shows significant benefit for patients with early breast cancer in interim analysisRibociclib plus endocrine therapy (ET) significantly reduced the risk of disease recurrence compared to standard ET alone in the adjuvant setting NATALEE is the first and only positive Phase III…
-
Media Release Achievements and AnnouncementsPhilippine FDA approves Novartis medicine brolucizumab for the treatment of visual impairment due to diabetic macular edemaThe Philippine Food and Drug Administration (FDA) has approved brolucizumab for the treatment of visual impairment due to diabetic macular edema (DME), a common microvascular complication in…
-
Media Release Partnerships and CommitmentsAPPIS 2023: Novartis, patient leaders to hold third annual regional summit to accelerate access, enhance health outcomesThe Alliance and Partnerships for Patient Innovation and Solutions (APPIS) platform will hold its third annual virtual Summit on March 20-21, 2023. Organized by Novartis and co-created by the…
-
Media Release Partnerships and CommitmentsWorld Kidney Day: Patient groups partner with Novartis to hold multistakeholder forum on enhancing health access of renal replacement therapy patientsChronic kidney disease (CKD) is among the leading causes of sickness and death in the Philippines. Latest estimates show that around 2.3 million Filipinos have CKD.3 The National Kidney and…
February 2023
-
Media ReleaseNovartis broadens access to innovative medicines, leverages data & digital for enhanced cancer care in PHNovartis continuously finds ways to help improve the quality of care for Filipino patients living with cancer, which is one of the leading causes of illness and death in the Philippines. In…
-
Media ReleaseNovartis associates take on challenge to unblock barriers to better cardiovascular healthTo help reduce the heavy burden of cardiovascular diseases (CVDs), Novartis launched the Unblocked movement for heart health – an initiative co-created with external stakeholders in the healthcare…
-
Media ReleaseNovartis: Working with DOH and other partners to end leprosyNovartis and the Novartis Foundation have been working with the Department of Health and other partners to eliminate leprosy for over 30 years. The Novartis Foundation focuses on influencing…